Vital Images appoints new VP

Article

Philip I. Smith has been named vice president of corporate development at Vital Images. The position was created to drive growth through the development of strategic relationships that will broaden sales and marketing channels and integrate new

Philip I. Smith has been named vice president of corporate development at Vital Images. The position was created to drive growth through the development of strategic relationships that will broaden sales and marketing channels and integrate new technologies. Smith will also be charged with pursuing any merger and acquisition efforts undertaken by the company.

Smith is an 11-year veteran of corporate finance, strategic planning, and market development positions in medical technology companies. Prior to joining Vital Images, he worked for two early-stage medical technology companies: as president and CEO of Thermonix in Minneapolis, and as vice president of marketing and business development for Image-Guided Neurologics in Melbourne, FL. Smith was previously an investment banker in the medical technology group of the investment firm US Bancorp Piper Jaffray and held senior sales positions at GE Medical Systems.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
Is Ultrasound or MRI More Effective for Diagnosing Peripheral Nerve Disorders in the Upper Extremities?

Is Ultrasound or MRI More Effective for Diagnosing Peripheral Nerve Disorders in the Upper Extremities?

Jeff Hall
March 6th 2025
Article

While high-resolution ultrasound offered nearly 10 percent higher specificity in the detection of upper extremity peripheral neuropathy, magnetic resonance neurography provided a nearly 23 percent higher sensitivity rate in a recent study.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

Jeff Hall
September 1st 2023
Podcast

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

GE HealthCare Debuts Genesis Enterprise Imaging Portfolio at HIMSS Conference

GE HealthCare Debuts Genesis Enterprise Imaging Portfolio at HIMSS Conference

Jeff Hall
March 5th 2025
Article

Offering four key software-as-a-service features, the cloud-based enterprise imaging suite reportedly offers enhanced security and storage and facilitates streamlined radiology workflows.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 2

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 2

Jeff Hall
August 23rd 2023
Podcast

In the second episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss recent studies published by the Journal of the American Medical Association (JAMA) that suggested moving to more of a risk-adapted model for mammography screening.

Study Examines Potential of Ultra-High Spatial Resolution Photon-Counting CT for Coronary Plaque Quantification

Study Examines Potential of Ultra-High Spatial Resolution Photon-Counting CT for Coronary Plaque Quantification

Jeff Hall
March 4th 2025
Article

Ultra-high spatial resolution with photon-counting CT facilitated a 33 percent reduction in the assessment of median total plaque volume and a 45 percent higher inter-reader agreement for evaluation of low-attenuation plaque volume in contrast to energy-integrating detector (EID) CT.

Is MRI Contrast Enhancement Necessary for Long-Term Monitoring of Diffuse Glioma?

Is MRI Contrast Enhancement Necessary for Long-Term Monitoring of Diffuse Glioma?

Jeff Hall
March 4th 2025
Article

In a comparison of contrast-enhanced T1-weighted (CET1w) MRI (and T2-weighted MRI/FLAIR imaging, researchers found that only three out of 82 cases of glioma progression were solely detected with CET1w MRI.

© 2025 MJH Life Sciences

All rights reserved.